These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 33802308)

  • 21. [Perioperative cardioprotection - From bench to bedside : Current experimental evidence and possible reasons for the limited translation into the clinical setting].
    Torregroza C; Roth S; Feige K; Lurati Buse G; Hollmann MW; Huhn R
    Anaesthesist; 2021 May; 70(5):401-412. PubMed ID: 33464375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What is Wrong With Cardiac Conditioning? We May be Shooting at Moving Targets.
    Iliodromitis EK; Cohen MV; Dagres N; Andreadou I; Kremastinos DT; Downey JM
    J Cardiovasc Pharmacol Ther; 2015 Jul; 20(4):357-69. PubMed ID: 25627214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gasotransmitters and noble gases in cardioprotection: unraveling molecular pathways for future therapeutic strategies.
    Pagliaro P; Weber NC; Femminò S; Alloatti G; Penna C
    Basic Res Cardiol; 2024 Aug; 119(4):509-544. PubMed ID: 38878210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perconditioning and postconditioning: current knowledge, knowledge gaps, barriers to adoption, and future directions.
    Vinten-Johansen J; Shi W
    J Cardiovasc Pharmacol Ther; 2011; 16(3-4):260-6. PubMed ID: 21821526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of Na
    Kingma JG
    J Cardiovasc Pharmacol Ther; 2018 May; 23(3):254-269. PubMed ID: 29562750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time to Give Up on Cardioprotection? A Critical Appraisal of Clinical Studies on Ischemic Pre-, Post-, and Remote Conditioning.
    Heusch G; Rassaf T
    Circ Res; 2016 Aug; 119(5):676-95. PubMed ID: 27539973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological targets revealed by myocardial postconditioning.
    Burley DS; Baxter GF
    Curr Opin Pharmacol; 2009 Apr; 9(2):177-88. PubMed ID: 19109069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological Cardioprotection against Ischemia Reperfusion Injury-The Search for a Clinical Effective Therapy.
    Wang Q; Zuurbier CJ; Huhn R; Torregroza C; Hollmann MW; Preckel B; van den Brom CE; Weber NC
    Cells; 2023 May; 12(10):. PubMed ID: 37408266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Remote conditioning the heart overview: translatability and mechanism.
    Schmidt MR; Redington A; Bøtker HE
    Br J Pharmacol; 2015 Apr; 172(8):1947-60. PubMed ID: 25219984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardioprotection by remote ischemic conditioning and its signal transduction.
    Kleinbongard P; Skyschally A; Heusch G
    Pflugers Arch; 2017 Feb; 469(2):159-181. PubMed ID: 27928644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of Myocardial Ischemia/Reperfusion Injury by Ischemic and Pharmacological Postconditioning.
    Heusch G
    Compr Physiol; 2015 Jul; 5(3):1123-45. PubMed ID: 26140711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge.
    Heusch G; Gersh BJ
    Eur Heart J; 2017 Mar; 38(11):774-784. PubMed ID: 27354052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Realizing the clinical potential of ischemic preconditioning and postconditioning.
    Yellon DM; Hausenloy DJ
    Nat Clin Pract Cardiovasc Med; 2005 Nov; 2(11):568-75. PubMed ID: 16258568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protecting the heart from ischemia/reperfusion injury: an update on remote ischemic preconditioning and postconditioning.
    Donato M; Evelson P; Gelpi RJ
    Curr Opin Cardiol; 2017 Nov; 32(6):784-790. PubMed ID: 28902715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ranolazine triggers pharmacological preconditioning and postconditioning in anesthetized rabbits through activation of RISK pathway.
    Efentakis P; Andreadou I; Bibli SI; Vasileiou S; Dagres N; Zoga A; Lougiakis N; Kremastinos DT; Iliodromitis EK
    Eur J Pharmacol; 2016 Oct; 789():431-438. PubMed ID: 27492365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Healing the diabetic heart: does myocardial preconditioning work?
    Balakumar P; Sharma NK
    Cell Signal; 2012 Jan; 24(1):53-9. PubMed ID: 21945408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenosine-A1 receptors activation restores the suppressed cardioprotective effects of ischemic preconditioning in hyperhomocysteinemic rat hearts.
    Balakumar P; Singh H; Reddy K; Anand-Srivastava MB
    J Cardiovasc Pharmacol; 2009 Sep; 54(3):204-12. PubMed ID: 19568176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TRPV1 and TRPV4 channels: potential therapeutic targets for ischemic conditioning-induced cardioprotection.
    Randhawa PK; Jaggi AS
    Eur J Pharmacol; 2015 Jan; 746():180-5. PubMed ID: 25449039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. State of the science of cardioprotection: Challenges and opportunities--proceedings of the 2010 NHLBI Workshop on Cardioprotection.
    Kloner RA; Schwartz Longacre L
    J Cardiovasc Pharmacol Ther; 2011; 16(3-4):223-32. PubMed ID: 21821520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.